Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Ann Surg Oncol ; 30(9): 5472-5485, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37340200

ABSTRACT

BACKGROUND: Involved lateral lymph nodes (LLNs) have been associated with increased local recurrence (LR) and ipsi-lateral LR (LLR) rates. However, consensus regarding the indication and type of surgical treatment for suspicious LLNs is lacking. This study evaluated the surgical treatment of LLNs in an untrained setting at a national level. METHODS: Patients who underwent additional LLN surgery were selected from a national cross-sectional cohort study regarding patients undergoing rectal cancer surgery in 69 Dutch hospitals in 2016. LLN surgery consisted of either 'node-picking' (the removal of an individual LLN) or 'partial regional node dissection' (PRND; an incomplete resection of the LLN area). For all patients with primarily enlarged (≥7 mm) LLNs, those undergoing rectal surgery with an additional LLN procedure were compared to those  undergoing only rectal resection. RESULTS: Out of 3057 patients, 64 underwent additional LLN surgery, with 4-year LR and LLR rates of 26% and 15%, respectively. Forty-eight patients (75%) had enlarged LLNs, with corresponding recurrence rates of 26% and 19%, respectively. Node-picking (n = 40) resulted in a 20% 4-year LLR, and a 14% LLR after PRND (n = 8; p = 0.677). Multivariable analysis of 158 patients with enlarged LLNs undergoing additional LLN surgery (n = 48) or rectal resection alone (n = 110) showed no significant association of LLN surgery with 4-year LR or LLR, but suggested higher recurrence risks after LLN surgery (LR: hazard ratio [HR] 1.5, 95% confidence interval [CI] 0.7-3.2, p = 0.264; LLR: HR 1.9, 95% CI 0.2-2.5, p = 0.874). CONCLUSION: Evaluation of Dutch practice in 2016 revealed that approximately one-third of patients with primarily enlarged LLNs underwent surgical treatment, mostly consisting of node-picking. Recurrence rates were not significantly affected by LLN surgery, but did suggest worse outcomes. Outcomes of LLN surgery after adequate training requires further research.


Subject(s)
Lymph Node Excision , Rectal Neoplasms , Humans , Lymph Node Excision/methods , Cross-Sectional Studies , Lymph Nodes/surgery , Lymph Nodes/pathology , Rectal Neoplasms/pathology , Rectum/pathology , Retrospective Studies , Neoplasm Recurrence, Local/surgery , Neoplasm Recurrence, Local/pathology , Neoplasm Staging
4.
Colorectal Dis ; 23(10): 2567-2574, 2021 10.
Article in English | MEDLINE | ID: mdl-34173995

ABSTRACT

AIM: Unlike meta-analyses of randomized controlled trials, population-based studies in colorectal cancer (CRC) patients have shown a significant association between open surgery and increased 30- and 90-day mortality compared with laparoscopic surgery. Long-term mortality, however, is scarcely reported. This retrospective population-based study aimed to compare long-term mortality after open and laparoscopic surgery for CRC. METHOD: The Dutch Colorectal Audit and the Dutch Cancer Centre registry were used to identify patients from three large nonacademic teaching hospitals who underwent curative resection for CRC between 2009 and 2018. Patients with relative contraindications for laparoscopic surgery (cT4 or pT4 tumours, distant metastasis requiring additional resection and emergency surgery) were excluded. Multivariable regression was used to assess the effect of laparoscopic surgery on long-term mortality with adjustment for gender, age, American Society of Anesthesiologists score, TNM stage, chemoradiation therapy and other confounders. RESULTS: We included 4531 patients, of whom 1298 (29%) underwent open surgery. The median follow-up was 43 months (interquartile range 23-71 months). Open surgery was associated with an increased risk of long-term mortality (adjusted hazard ratio 1.26, 95% confidence interval 1.10-1.45, p = 0.001). Mixed-effects Cox regression with year of surgery as a random effect also showed an increased risk after open surgery (adjusted hazard ratio 1.33, 95% confidence interval 1.11-1.52, p = 0.004). CONCLUSION: Open surgery seems to be associated with increased long-term mortality in the elective setting for CRC patients. A minimally invasive approach might improve long-term outcomes.


Subject(s)
Colorectal Neoplasms , Laparoscopy , Colectomy , Colorectal Neoplasms/surgery , Elective Surgical Procedures , Humans , Retrospective Studies , Treatment Outcome
5.
Ned Tijdschr Geneeskd ; 157(6): A4400, 2013.
Article in Dutch | MEDLINE | ID: mdl-23388134

ABSTRACT

A 44-year old woman came with an ulcerating wound, covering both mammas and axillas. Because of an extreme fear for doctors, the woman hid this for more than a year. The diagnoses was an inoperable T4N3M1 mamma carcinoma. Patient was treated with palliative hormonal therapy with good effects.


Subject(s)
Adenocarcinoma/diagnosis , Breast Neoplasms/diagnosis , Breast/pathology , Adenocarcinoma/drug therapy , Adult , Antineoplastic Agents/therapeutic use , Breast Neoplasms/drug therapy , Female , Humans , Palliative Care , Skin Ulcer/diagnosis , Skin Ulcer/etiology
6.
Am J Surg ; 200(4): 446-53, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20409512

ABSTRACT

BACKGROUND: High recurrence rates determine the dismal outcome in esophageal cancer. We reviewed our experiences and defined prognostic factors and patterns of recurrences after curatively intended transthoracic esophagectomy. METHODS: Between January 1991 and December 2005, 212 consecutive patients underwent a radical transthoracic esophagectomy with extended 2-field lymphadenectomy. Recurrence rates, survival, and prognostic factors were analyzed (minimal follow-up period, 2 y). RESULTS: Radicality was obtained in 85.6%. The median follow-up period was 26.6 months. The overall recurrence rate at 1, 3, and 5 years was 28%, 44%, and 64%, respectively, and locoregional recurrence rate was 17%, 27%, and 43%, respectively. Overall survival rates, including postoperative deaths, were 45% and 34% at 3 and 5 years, respectively. pT stage and lymph node (LN) ratio greater than .20 were independent prognostic factors for survival and recurrences. Radicality was most prognostic for survival, and for N+ greater than 4 positive LN for recurrences. CONCLUSIONS: Radicality and LN ratio are strong prognostic factors. High radicality and adequate nodal assessment are guaranteed by an extended transthoracic approach.


Subject(s)
Esophageal Neoplasms/surgery , Esophagectomy/methods , Neoplasm Recurrence, Local/prevention & control , Aged , Aged, 80 and over , Biopsy, Fine-Needle , Endosonography , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/epidemiology , Female , Follow-Up Studies , Humans , Incidence , Lymph Node Excision , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/epidemiology , Neoplasm Staging , Netherlands/epidemiology , Positron-Emission Tomography , Prognosis , Retrospective Studies , Survival Rate/trends , Time Factors , Tomography, X-Ray Computed
7.
Ann Surg Oncol ; 17(3): 812-20, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19924487

ABSTRACT

BACKGROUND: In esophageal cancer, circumferential resection margins (CRMs) are considered to be of relevant prognostic value, but a reliable definition of tumor-free CRM is still unclear. The aim of this study was to appraise the clinical prognostic value of microscopic CRM involvement and to determine the optimal limit of CRM. METHODS: To define the optimal tumor-free CRM we included 98 consecutive patients who underwent extended esophagectomy with microscopic tumor-free resection margins (R0) between 1997 and 2006. CRMs were measured in tenths of millimeters with inked lateral margins. Outcome of patients with CRM involvement was compared with a statistically comparable control group of 21 patients with microscopic positive resection margins (R1). RESULTS: A cutoff point of CRM at < or = 1.0 mm and > 1.0 mm appeared to be an adequate marker for survival and prognosis (both P < 0.001). The outcome in patients with CRMs < or = 1.0 and > 0 mm was equal to that in patients with CRM of 0 mm (P = 0.43). CRM involvement was an independent prognostic factor for both recurrent disease (P = 0.001) and survival (P < 0.001). Survival of patients with positive CRMs (< or = 1 mm) did not significantly differ from patients with an R1 resection (P = 0.12). CONCLUSION: Involvement of the circumferential resection margins is an independent prognostic factor for recurrent disease and survival in esophageal cancer. The optimal limit for a positive CRM is < or = 1 mm and for a free CRM is >1.0 mm. Patients with unfavorable CRM should be approached as patients with R1 resection with corresponding outcome.


Subject(s)
Adenocarcinoma/surgery , Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Esophagectomy , Neoplasm Recurrence, Local/surgery , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Esophageal Neoplasms/pathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Prognosis , Survival Rate
8.
J Surg Oncol ; 100(8): 699-702, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-19731246

ABSTRACT

BACKGROUND: To detect anastomotic leakage after esophagectomy in esophageal carcinoma patients, many surgeons perform a radiological contrast examination routinely. The aim of this retrospective study is to determine the clinical relevance of a routine contrast examination after esophagectomy and to evaluate criteria for contrast examination on demand. METHODS: Data were obtained from 211 patients with cancer of the esophagus or gastro-esophageal junction who underwent an esophagectomy during the period 1991-2004. Retrospectively, we analyzed patients regarding anastomosis-related characteristics and clinical signs including sepsis, fever > or = 39.0 degrees C, leukocytosis > or = 20 x 10(9)/ml and pleural effusion. RESULTS: Anastomotic leakage had appeared in 35 of the 211 patients. The clinical signs sepsis (odds ratio (OR) 6.72: 95% confidence interval (CI) (2.57-17.56); P < 0.0001), leukocytosis (OR 2.62 (1.10-6.22); P < 0.030), and fever (OR 2.34 (1.01-5.42); P < 0.047) were significantly related to anastomotic leakage. Pleural effusion was not significantly related to anastomotic leakage (OR 2.83 (0.98-8.13); P = 0.054). CONCLUSION: Our study suggests that the clinical value for a routinely performed contrast examination is debatable. We recommend performing a contrast examination based on clinical suspicion and clinical signs of anastomotic leakage including sepsis, fever > or = 39.0 degrees C and leukocytosis > or = 20 x 10(9)/ml.


Subject(s)
Anastomosis, Surgical/adverse effects , Contrast Media , Esophagectomy/adverse effects , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Retrospective Studies , Tomography, X-Ray Computed
9.
Anticancer Res ; 28(3B): 1867-73, 2008.
Article in English | MEDLINE | ID: mdl-18630473

ABSTRACT

BACKGROUND: Recently, positron emission tomography/computed tomography (PET/CT) has been introduced in the staging of oesophageal cancer. The impact of PET/CT fusion in comparison with side-by-side PET/CT in these tumours, was analyzed. PATIENTS AND METHODS: In 61 patients, 18-F-fluorodeoxyglucose (FDG)-PET and multidetector (md)-CT were performed within a two week interval. Software-fusion of md-CT and FDG-PET was correlated with side-by-side FDG-PET/CT reading by two independent investigators. The gold standard was the pathological outcome or clinical evidence of progression during the first year of follow-up. RESULTS: In 18 patients (18/61; 30%), nodal staging improved with software-fusion. The number of nodal metastases increased in five patients and decreased in four patients, leading to up-staging in one patient (2%) and down-staging in three patients (5%). In nine cases (15%), certainty and localization of metastases improved. However, the number of distant metastases did not change and software-fusion did not have an influence on resectability. CONCLUSION: PET/CT fusion substantially improves detection and localization of nodal metastases and may have an impact on locoregional treatment options.


Subject(s)
Esophageal Neoplasms/diagnostic imaging , Lymph Nodes/diagnostic imaging , Aged , Aged, 80 and over , Esophageal Neoplasms/pathology , Female , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging , Positron-Emission Tomography/methods , Radiopharmaceuticals , Retrospective Studies , Tomography, X-Ray Computed/methods
10.
Anticancer Res ; 26(3B): 2289-93, 2006.
Article in English | MEDLINE | ID: mdl-16821604

ABSTRACT

BACKGROUND: The outcome of different palliative regimens was investigated in patients with incurable oesophageal carcinoma identified during surgical exploration. PATIENTS AND METHODS: Between January 1992 and December 2002, 203 patients with oesophageal cancer underwent surgery after a standard staging procedure including computer tomography and endoscopic ultrasonography. The data from 78 patients, rendered incurable at exploration and who subsequently underwent palliative interventions, were analysed retrospectively. RESULTS: The median survival in the whole group was 8.9 (1-105) months. Patients treated with chemotherapy had a higher median survival of 11.6 months compared with that of the other palliatively-treated patients: 8.4 months (p=0.003). Overall, intraluminal stenting was the palliative measure of dysphagia in 25 patients (32.3%). CONCLUSION: Patients with incurable oesophageal carcinoma have a poor overall survival of less than 9 months. Stenting is frequently (32%) needed for ultimate palliation of dysphagia after primary treatment. In a selective group, palliative chemotherapy offered a survival benefit compared with other treatment modalities.


Subject(s)
Esophageal Neoplasms/therapy , Palliative Care/methods , Adult , Aged , Aged, 80 and over , Esophageal Neoplasms/pathology , Female , Humans , Male , Middle Aged , Neoplasm Metastasis , Retrospective Studies , Survival Rate , Treatment Outcome
11.
J Pediatr Surg ; 40(12): e1-4, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16338286

ABSTRACT

Esophageal cancer development after previous atresia repair is extremely rare in young patients. We present the clinical course of a patient who developed an adenocarcinoma of the esophagus at the age of 22 years, after repair of a tracheoesophageal fistula with esophageal atresia in the neonatal period. She developed a stricture of the esophageal anastomosis requiring frequent dilatations. Six years after an antireflux procedure because of a difficult treatable severe gastroesophageal reflux, an advanced adenocarcinoma was detected at the site of the end-to-end anastomosis of the previous atresia.


Subject(s)
Adenocarcinoma/etiology , Esophageal Atresia/surgery , Esophageal Neoplasms/etiology , Adenocarcinoma/pathology , Adult , Anastomosis, Surgical , Esophageal Neoplasms/pathology , Esophagus/surgery , Female , Gastroesophageal Reflux , Humans , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...